結核(TB)治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2989)
◆英語タイトル:Global Tuberculosis (TB) Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2989
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月
◆ページ数:95
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥444,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥666,900見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥889,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、結核(TB)治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(イソニアジド、リファンピン(リファディン、リマクタン)、エタンブトール(ミアンブトール)、ピラジナミド)、用途別市場規模(活動性結核、潜在性結核)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・結核(TB)治療の市場動向
・企業の競争状況、市場シェア
・結核(TB)治療の種類別市場規模(イソニアジド、リファンピン(リファディン、リマクタン)、エタンブトール(ミアンブトール)、ピラジナミド)
・結核(TB)治療の用途別市場規模(活動性結核、潜在性結核)
・結核(TB)治療の北米市場規模2016-2027(アメリカ、カナダ)
・結核(TB)治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・結核(TB)治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・結核(TB)治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・結核(TB)治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Johnson & Johnson、Otsuka Pharmaceutical Co., Ltd、Macleods Pharmaceutical Ltd、Dong-A ST Co., Ltd、Lupin Ltd、Janssen Products, LP、Mylan、Sanofi)
・結論
【レポートの概要】

If you have latent tuberculosis, you may need to take only one or two types of TB drug. Active tuberculosis, particularly if it’s a drug-resistant strain, will require several drugs at once. The most common medications used to treat tuberculosis include:
Isoniazid
Rifampin (Rifadin, Rimactane)
Ethambutol (Myambutol)
Pyrazinamide

Market Analysis and Insights: Global Tuberculosis (TB) Treatment Market
The global Tuberculosis (TB) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tuberculosis (TB) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tuberculosis (TB) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tuberculosis (TB) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tuberculosis (TB) Treatment market.

Global Tuberculosis (TB) Treatment Scope and Market Size
Tuberculosis (TB) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tuberculosis (TB) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Isoniazid
Rifampin (Rifadin, Rimactane)
Ethambutol (Myambutol)
Pyrazinamide

Segment by Application
Active TB
Latent TB

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Johnson & Johnson
Otsuka Pharmaceutical Co., Ltd
Macleods Pharmaceutical Ltd
Dong-A ST Co., Ltd
Lupin Ltd
Janssen Products, LP
Mylan
Sanofi

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis (TB) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Isoniazid
1.2.3 Rifampin (Rifadin, Rimactane)
1.2.4 Ethambutol (Myambutol)
1.2.5 Pyrazinamide
1.3 Market by Application
1.3.1 Global Tuberculosis (TB) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Active TB
1.3.3 Latent TB
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Tuberculosis (TB) Treatment Market Perspective (2016-2027)
2.2 Tuberculosis (TB) Treatment Growth Trends by Regions
2.2.1 Tuberculosis (TB) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Tuberculosis (TB) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Tuberculosis (TB) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Tuberculosis (TB) Treatment Industry Dynamic
2.3.1 Tuberculosis (TB) Treatment Market Trends
2.3.2 Tuberculosis (TB) Treatment Market Drivers
2.3.3 Tuberculosis (TB) Treatment Market Challenges
2.3.4 Tuberculosis (TB) Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis (TB) Treatment Players by Revenue
3.1.1 Global Top Tuberculosis (TB) Treatment Players by Revenue (2016-2021)
3.1.2 Global Tuberculosis (TB) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Tuberculosis (TB) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tuberculosis (TB) Treatment Revenue
3.4 Global Tuberculosis (TB) Treatment Market Concentration Ratio
3.4.1 Global Tuberculosis (TB) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis (TB) Treatment Revenue in 2020
3.5 Tuberculosis (TB) Treatment Key Players Head office and Area Served
3.6 Key Players Tuberculosis (TB) Treatment Product Solution and Service
3.7 Date of Enter into Tuberculosis (TB) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Tuberculosis (TB) Treatment Breakdown Data by Type
4.1 Global Tuberculosis (TB) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Tuberculosis (TB) Treatment Forecasted Market Size by Type (2022-2027)

5 Tuberculosis (TB) Treatment Breakdown Data by Application
5.1 Global Tuberculosis (TB) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Tuberculosis (TB) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Tuberculosis (TB) Treatment Market Size (2016-2027)
6.2 North America Tuberculosis (TB) Treatment Market Size by Type
6.2.1 North America Tuberculosis (TB) Treatment Market Size by Type (2016-2021)
6.2.2 North America Tuberculosis (TB) Treatment Market Size by Type (2022-2027)
6.2.3 North America Tuberculosis (TB) Treatment Market Size by Type (2016-2027)
6.3 North America Tuberculosis (TB) Treatment Market Size by Application
6.3.1 North America Tuberculosis (TB) Treatment Market Size by Application (2016-2021)
6.3.2 North America Tuberculosis (TB) Treatment Market Size by Application (2022-2027)
6.3.3 North America Tuberculosis (TB) Treatment Market Size by Application (2016-2027)
6.4 North America Tuberculosis (TB) Treatment Market Size by Country
6.4.1 North America Tuberculosis (TB) Treatment Market Size by Country (2016-2021)
6.4.2 North America Tuberculosis (TB) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Tuberculosis (TB) Treatment Market Size (2016-2027)
7.2 Europe Tuberculosis (TB) Treatment Market Size by Type
7.2.1 Europe Tuberculosis (TB) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Tuberculosis (TB) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Tuberculosis (TB) Treatment Market Size by Type (2016-2027)
7.3 Europe Tuberculosis (TB) Treatment Market Size by Application
7.3.1 Europe Tuberculosis (TB) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Tuberculosis (TB) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Tuberculosis (TB) Treatment Market Size by Application (2016-2027)
7.4 Europe Tuberculosis (TB) Treatment Market Size by Country
7.4.1 Europe Tuberculosis (TB) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Tuberculosis (TB) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis (TB) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Type
8.2.1 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Application
8.3.1 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Region
8.4.1 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Tuberculosis (TB) Treatment Market Size (2016-2027)
9.2 Latin America Tuberculosis (TB) Treatment Market Size by Type
9.2.1 Latin America Tuberculosis (TB) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Tuberculosis (TB) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Tuberculosis (TB) Treatment Market Size by Type (2016-2027)
9.3 Latin America Tuberculosis (TB) Treatment Market Size by Application
9.3.1 Latin America Tuberculosis (TB) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Tuberculosis (TB) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Tuberculosis (TB) Treatment Market Size by Application (2016-2027)
9.4 Latin America Tuberculosis (TB) Treatment Market Size by Country
9.4.1 Latin America Tuberculosis (TB) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Tuberculosis (TB) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis (TB) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Type
10.2.1 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Application
10.3.1 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Country
10.4.1 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Tuberculosis (TB) Treatment Introduction
11.1.4 Johnson & Johnson Revenue in Tuberculosis (TB) Treatment Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 Otsuka Pharmaceutical Co., Ltd
11.2.1 Otsuka Pharmaceutical Co., Ltd Company Details
11.2.2 Otsuka Pharmaceutical Co., Ltd Business Overview
11.2.3 Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Introduction
11.2.4 Otsuka Pharmaceutical Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2016-2021)
11.2.5 Otsuka Pharmaceutical Co., Ltd Recent Development
11.3 Macleods Pharmaceutical Ltd
11.3.1 Macleods Pharmaceutical Ltd Company Details
11.3.2 Macleods Pharmaceutical Ltd Business Overview
11.3.3 Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Introduction
11.3.4 Macleods Pharmaceutical Ltd Revenue in Tuberculosis (TB) Treatment Business (2016-2021)
11.3.5 Macleods Pharmaceutical Ltd Recent Development
11.4 Dong-A ST Co., Ltd
11.4.1 Dong-A ST Co., Ltd Company Details
11.4.2 Dong-A ST Co., Ltd Business Overview
11.4.3 Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Introduction
11.4.4 Dong-A ST Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2016-2021)
11.4.5 Dong-A ST Co., Ltd Recent Development
11.5 Lupin Ltd
11.5.1 Lupin Ltd Company Details
11.5.2 Lupin Ltd Business Overview
11.5.3 Lupin Ltd Tuberculosis (TB) Treatment Introduction
11.5.4 Lupin Ltd Revenue in Tuberculosis (TB) Treatment Business (2016-2021)
11.5.5 Lupin Ltd Recent Development
11.6 Janssen Products, LP
11.6.1 Janssen Products, LP Company Details
11.6.2 Janssen Products, LP Business Overview
11.6.3 Janssen Products, LP Tuberculosis (TB) Treatment Introduction
11.6.4 Janssen Products, LP Revenue in Tuberculosis (TB) Treatment Business (2016-2021)
11.6.5 Janssen Products, LP Recent Development
11.7 Mylan
11.7.1 Mylan Company Details
11.7.2 Mylan Business Overview
11.7.3 Mylan Tuberculosis (TB) Treatment Introduction
11.7.4 Mylan Revenue in Tuberculosis (TB) Treatment Business (2016-2021)
11.7.5 Mylan Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Tuberculosis (TB) Treatment Introduction
11.8.4 Sanofi Revenue in Tuberculosis (TB) Treatment Business (2016-2021)
11.8.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Tuberculosis (TB) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Isoniazid
Table 3. Key Players of Rifampin (Rifadin, Rimactane)
Table 4. Key Players of Ethambutol (Myambutol)
Table 5. Key Players of Pyrazinamide
Table 6. Global Tuberculosis (TB) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Tuberculosis (TB) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Tuberculosis (TB) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Tuberculosis (TB) Treatment Market Share by Regions (2016-2021)
Table 10. Global Tuberculosis (TB) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Tuberculosis (TB) Treatment Market Share by Regions (2022-2027)
Table 12. Tuberculosis (TB) Treatment Market Trends
Table 13. Tuberculosis (TB) Treatment Market Drivers
Table 14. Tuberculosis (TB) Treatment Market Challenges
Table 15. Tuberculosis (TB) Treatment Market Restraints
Table 16. Global Tuberculosis (TB) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Tuberculosis (TB) Treatment Market Share by Players (2016-2021)
Table 18. Global Top Tuberculosis (TB) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis (TB) Treatment as of 2020)
Table 19. Ranking of Global Top Tuberculosis (TB) Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Tuberculosis (TB) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Tuberculosis (TB) Treatment Product Solution and Service
Table 23. Date of Enter into Tuberculosis (TB) Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Tuberculosis (TB) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Tuberculosis (TB) Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Tuberculosis (TB) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Tuberculosis (TB) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Tuberculosis (TB) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Tuberculosis (TB) Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Tuberculosis (TB) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Tuberculosis (TB) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Tuberculosis (TB) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Tuberculosis (TB) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Tuberculosis (TB) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Tuberculosis (TB) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Tuberculosis (TB) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Tuberculosis (TB) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Tuberculosis (TB) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Tuberculosis (TB) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Tuberculosis (TB) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Tuberculosis (TB) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Tuberculosis (TB) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Tuberculosis (TB) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Tuberculosis (TB) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Tuberculosis (TB) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Tuberculosis (TB) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Tuberculosis (TB) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Tuberculosis (TB) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Tuberculosis (TB) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Tuberculosis (TB) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Tuberculosis (TB) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Tuberculosis (TB) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Tuberculosis (TB) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Tuberculosis (TB) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Tuberculosis (TB) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Tuberculosis (TB) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Tuberculosis (TB) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Tuberculosis (TB) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Tuberculosis (TB) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Tuberculosis (TB) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Tuberculosis (TB) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Johnson & Johnson Company Details
Table 64. Johnson & Johnson Business Overview
Table 65. Johnson & Johnson Tuberculosis (TB) Treatment Product
Table 66. Johnson & Johnson Revenue in Tuberculosis (TB) Treatment Business (2016-2021) & (US$ Million)
Table 67. Johnson & Johnson Recent Development
Table 68. Otsuka Pharmaceutical Co., Ltd Company Details
Table 69. Otsuka Pharmaceutical Co., Ltd Business Overview
Table 70. Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Product
Table 71. Otsuka Pharmaceutical Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2016-2021) & (US$ Million)
Table 72. Otsuka Pharmaceutical Co., Ltd Recent Development
Table 73. Macleods Pharmaceutical Ltd Company Details
Table 74. Macleods Pharmaceutical Ltd Business Overview
Table 75. Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Product
Table 76. Macleods Pharmaceutical Ltd Revenue in Tuberculosis (TB) Treatment Business (2016-2021) & (US$ Million)
Table 77. Macleods Pharmaceutical Ltd Recent Development
Table 78. Dong-A ST Co., Ltd Company Details
Table 79. Dong-A ST Co., Ltd Business Overview
Table 80. Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Product
Table 81. Dong-A ST Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2016-2021) & (US$ Million)
Table 82. Dong-A ST Co., Ltd Recent Development
Table 83. Lupin Ltd Company Details
Table 84. Lupin Ltd Business Overview
Table 85. Lupin Ltd Tuberculosis (TB) Treatment Product
Table 86. Lupin Ltd Revenue in Tuberculosis (TB) Treatment Business (2016-2021) & (US$ Million)
Table 87. Lupin Ltd Recent Development
Table 88. Janssen Products, LP Company Details
Table 89. Janssen Products, LP Business Overview
Table 90. Janssen Products, LP Tuberculosis (TB) Treatment Product
Table 91. Janssen Products, LP Revenue in Tuberculosis (TB) Treatment Business (2016-2021) & (US$ Million)
Table 92. Janssen Products, LP Recent Development
Table 93. Mylan Company Details
Table 94. Mylan Business Overview
Table 95. Mylan Tuberculosis (TB) Treatment Product
Table 96. Mylan Revenue in Tuberculosis (TB) Treatment Business (2016-2021) & (US$ Million)
Table 97. Mylan Recent Development
Table 98. Sanofi Company Details
Table 99. Sanofi Business Overview
Table 100. Sanofi Revenue in Tuberculosis (TB) Treatment Business (2016-2021) & (US$ Million)
Table 101. Sanofi Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tuberculosis (TB) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Isoniazid Features
Figure 3. Rifampin (Rifadin, Rimactane) Features
Figure 4. Ethambutol (Myambutol) Features
Figure 5. Pyrazinamide Features
Figure 6. Global Tuberculosis (TB) Treatment Market Share by Application: 2020 VS 2027
Figure 7. Active TB Case Studies
Figure 8. Latent TB Case Studies
Figure 9. Tuberculosis (TB) Treatment Report Years Considered
Figure 10. Global Tuberculosis (TB) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Tuberculosis (TB) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Tuberculosis (TB) Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Tuberculosis (TB) Treatment Market Share by Regions (2022-2027)
Figure 14. Global Tuberculosis (TB) Treatment Market Share by Players in 2020
Figure 15. Global Top Tuberculosis (TB) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis (TB) Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Tuberculosis (TB) Treatment Revenue in 2020
Figure 17. Global Tuberculosis (TB) Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Tuberculosis (TB) Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Tuberculosis (TB) Treatment Market Share by Type (2016-2027)
Figure 21. North America Tuberculosis (TB) Treatment Market Share by Application (2016-2027)
Figure 22. North America Tuberculosis (TB) Treatment Market Share by Country (2016-2027)
Figure 23. United States Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Tuberculosis (TB) Treatment Market Share by Type (2016-2027)
Figure 27. Europe Tuberculosis (TB) Treatment Market Share by Application (2016-2027)
Figure 28. Europe Tuberculosis (TB) Treatment Market Share by Country (2016-2027)
Figure 29. Germany Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Tuberculosis (TB) Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Tuberculosis (TB) Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Tuberculosis (TB) Treatment Market Share by Region (2016-2027)
Figure 39. China Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Tuberculosis (TB) Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Tuberculosis (TB) Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Tuberculosis (TB) Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Tuberculosis (TB) Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Tuberculosis (TB) Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Tuberculosis (TB) Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Tuberculosis (TB) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Johnson & Johnson Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2016-2021)
Figure 59. Otsuka Pharmaceutical Co., Ltd Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2016-2021)
Figure 60. Macleods Pharmaceutical Ltd Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2016-2021)
Figure 61. Dong-A ST Co., Ltd Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2016-2021)
Figure 62. Lupin Ltd Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2016-2021)
Figure 63. Janssen Products, LP Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2016-2021)
Figure 64. Mylan Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2016-2021)
Figure 65. Sanofi Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed


【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 結核(TB)治療の世界市場規模・現状・予測2021年-2027年(Global Tuberculosis (TB) Treatment Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。